Black Diamond Therapeutics (BDTX) News Today $3.89 +0.16 (+4.29%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$3.89 0.00 (0.00%) As of 10/3/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BDTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Black Diamond Therapeutics initiated with a Buy at Freedom CapitalOctober 1 at 6:31 AM | msn.comBrokerages Set Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) PT at $11.00September 27, 2025 | americanbankingnews.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Recommendation of "Buy" from AnalystsSeptember 24, 2025 | marketbeat.comGuggenheim Sets $8 Price Target as Black Diamond Therapeutics, Inc. (BDTX) Prepares Phase 2 ResultsSeptember 16, 2025 | msn.comShareholders in Black Diamond Therapeutics (NASDAQ:BDTX) are in the red if they invested five years agoSeptember 15, 2025 | finance.yahoo.comBlack Diamond Therapeutics (NASDAQ:BDTX) Coverage Initiated by Analysts at GuggenheimSeptember 8, 2025 | marketbeat.comGuggenheim Initiates Coverage of Black Diamond Therapeutics (BDTX) with Buy RecommendationSeptember 5, 2025 | msn.comAWM Investment Company Inc. Invests $775,000 in Black Diamond Therapeutics, Inc. $BDTXSeptember 5, 2025 | marketbeat.comBlack Diamond Therapeutics initiated with a Buy at GuggenheimSeptember 4, 2025 | msn.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Given Average Recommendation of "Buy" by BrokeragesSeptember 1, 2025 | marketbeat.comAffinity Asset Advisors LLC Cuts Position in Black Diamond Therapeutics, Inc. $BDTXAugust 28, 2025 | marketbeat.comBlack Diamond Therapeutics: A Potential First-Line In NSCLC Trading At CashAugust 25, 2025 | seekingalpha.comEquities Analysts Offer Predictions for BDTX Q3 EarningsAugust 16, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for BDTX FY2026 Earnings?August 15, 2025 | marketbeat.comBlack Diamond Therapeutics (NASDAQ:BDTX) Given New $10.00 Price Target at HC WainwrightAugust 12, 2025 | marketbeat.comWedbush Issues Pessimistic Estimate for BDTX EarningsAugust 12, 2025 | marketbeat.comBlack Diamond Therapeutics (NASDAQ:BDTX) Announces Earnings Results, Beats Estimates By $0.06 EPSAugust 11, 2025 | marketbeat.comBlack Diamond Therapeutics (NASDAQ:BDTX) Downgraded by Wall Street Zen to "Hold"August 10, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?August 9, 2025 | finance.yahoo.comBlack Diamond Therapeutics, Inc: Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 9, 2025 | finanznachrichten.deBlack Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 7, 2025 | globenewswire.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Given Average Rating of "Buy" by BrokeragesAugust 5, 2025 | marketbeat.comBlack Diamond Therapeutics (BDTX) Expected to Announce Earnings on TuesdayJuly 30, 2025 | marketbeat.comBrown Wealth Management LLC Purchases Shares of 100,000 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)July 27, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows PromiseJuly 15, 2025 | msn.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Rating of "Buy" from AnalystsJuly 11, 2025 | marketbeat.comBlack Diamond Therapeutics (NASDAQ:BDTX) Coverage Initiated at Raymond James FinancialJuly 1, 2025 | marketbeat.comBlack Diamond Therapeutics Inc. BDTX (U.S.: Nasdaq) - The Wall Street JournalJune 25, 2025 | wsj.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Rating of "Buy" from AnalystsJune 16, 2025 | marketbeat.comBlack Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Wall Street ZenJune 14, 2025 | marketbeat.comBlack Diamond Therapeutics: Targeted Approach And Early Efficacy Signals Create Potential For Significant UpsideJune 10, 2025 | seekingalpha.comBlack Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Lowered by Wall Street ZenJune 6, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Purchased by Millennium Management LLCJune 5, 2025 | marketbeat.comShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Declines By 14.4%June 4, 2025 | marketbeat.comBlack Diamond Therapeutics to Participate in Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Recommendation of "Buy" from BrokeragesMay 24, 2025 | marketbeat.comBlack Diamond Therapeutics (NASDAQ:BDTX) Rating Increased to Buy at StockNews.comMay 24, 2025 | marketbeat.comVestal Point Capital LP Raises Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 21, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Cuts Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 21, 2025 | marketbeat.comTang Capital Management LLC Purchases 700,000 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 20, 2025 | marketbeat.comDimensional Fund Advisors LP Has $1.42 Million Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 18, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLCMay 17, 2025 | marketbeat.comTD Cowen Remains a Buy on Black Diamond Therapeutics (BDTX)May 15, 2025 | theglobeandmail.comBlack Diamond Therapeutics, Inc: Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 13, 2025 | finanznachrichten.deBlack Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 12, 2025 | globenewswire.comPositive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past yearMay 4, 2025 | finance.yahoo.comBoxer Capital Management LLC Acquires New Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 4, 2025 | marketbeat.comBlack Diamond Therapeutics (BDTX) to Release Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Sells 267,668 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)April 29, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Bought by Renaissance Technologies LLCApril 28, 2025 | marketbeat.com Get Black Diamond Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BDTX Media Mentions By Week BDTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BDTX News Sentiment▼1.140.53▲Average Medical News Sentiment BDTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BDTX Articles This Week▼22▲BDTX Articles Average Week Get the Latest News and Ratings for BDTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Black Diamond Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies OCS News Today IOVA News Today VIR News Today GHRS News Today AVXL News Today PROK News Today AVBP News Today AKBA News Today MRVI News Today PRME News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BDTX) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
